<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR110">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ye</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Yehenala</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>Y</given-names>
   </name>
  </person-group>
  <article-title>Safety and efficacy assessment of allogenic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (phase I/II)</article-title>
  <source>Trials</source>
  <year>2020</year>
  <volume>21</volume>
  <fpage>520</fpage>
  <?supplied-pmid 32532356?>
  <pub-id pub-id-type="pmid">32532356</pub-id>
 </element-citation>
</ref>
